Nanobiotix S.A.s 27 percent Dip Still Leaving Some Shareholders Feeling Restless Over Its PSRatio - Simply Wall St
| NANO Stock | EUR 3.22 0.07 2.13% |
About 61% of Nanobiotix's investor base is looking to short. The analysis of current outlook of investing in Nanobiotix SA suggests that many traders are alarmed regarding Nanobiotix's prospects. The current market sentiment, together with Nanobiotix's historical and current headlines, can help investors time the market. In addition, many technical investors use Nanobiotix SA stock news signals to limit their universe of possible portfolio assets.
Nanobiotix |
Nanobiotix S.A.s 27 percent Dip Still Leaving Some Shareholders Feeling Restless Over Its PSRatio Simply Wall St
Read at news.google.com
 |
Nanobiotix Fundamental Analysis
We analyze Nanobiotix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanobiotix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanobiotix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Nanobiotix is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Nanobiotix SA Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nanobiotix stock to make a market-neutral strategy. Peer analysis of Nanobiotix could also be used in its relative valuation, which is a method of valuing Nanobiotix by comparing valuation metrics with similar companies.
Peers
Nanobiotix Related Equities
Complementary Tools for Nanobiotix Stock analysis
When running Nanobiotix's price analysis, check to measure Nanobiotix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobiotix is operating at the current time. Most of Nanobiotix's value examination focuses on studying past and present price action to predict the probability of Nanobiotix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobiotix's price. Additionally, you may evaluate how the addition of Nanobiotix to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |